Raymond James Financial Inc. purchased a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 52,503 shares of the company's stock, valued at approximately $1,103,000. Raymond James Financial Inc. owned approximately 0.13% of Phibro Animal Health as of its most recent SEC filing.
Other large investors have also recently modified their holdings of the company. Rhumbline Advisers raised its position in Phibro Animal Health by 0.6% during the fourth quarter. Rhumbline Advisers now owns 76,582 shares of the company's stock valued at $1,608,000 after purchasing an additional 484 shares in the last quarter. Los Angeles Capital Management LLC raised its holdings in shares of Phibro Animal Health by 2.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 24,042 shares of the company's stock valued at $505,000 after buying an additional 503 shares in the last quarter. New York State Teachers Retirement System lifted its position in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company's stock worth $114,000 after buying an additional 775 shares during the last quarter. SG Americas Securities LLC boosted its stake in Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock worth $276,000 after buying an additional 906 shares in the last quarter. Finally, Globeflex Capital L P grew its position in Phibro Animal Health by 0.8% during the fourth quarter. Globeflex Capital L P now owns 206,595 shares of the company's stock valued at $4,338,000 after acquiring an additional 1,700 shares during the last quarter. Institutional investors own 99.34% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on PAHC shares. Morgan Stanley boosted their price objective on shares of Phibro Animal Health from $20.00 to $21.00 and gave the stock an "equal weight" rating in a report on Thursday. StockNews.com raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday. Finally, Barclays raised their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $20.00.
View Our Latest Research Report on Phibro Animal Health
Phibro Animal Health Trading Up 1.0 %
NASDAQ:PAHC traded up $0.23 during midday trading on Friday, reaching $22.48. 317,954 shares of the stock traded hands, compared to its average volume of 194,137. The stock has a market capitalization of $910.51 million, a P/E ratio of 46.83, a PEG ratio of 0.45 and a beta of 0.62. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company has a fifty day moving average of $19.99 and a 200 day moving average of $21.84. Phibro Animal Health Co. has a 12 month low of $16.16 and a 12 month high of $26.55.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. The company had revenue of $347.80 million during the quarter, compared to analyst estimates of $352.41 million. On average, research analysts predict that Phibro Animal Health Co. will post 1.95 EPS for the current year.
Phibro Animal Health Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Investors of record on Wednesday, June 4th will be issued a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, June 4th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.14%. Phibro Animal Health's dividend payout ratio is presently 100.00%.
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
